Multidrug Machine Learning Models for Predicting Human Immunodeficiency Virus‐1 Reverse Transcriptase Inhibitor Resistance
ChemMedChem · 2026-11-26 · 21 (22)
DOI: 10.1002/cmdc.70556 ↗At a glance
Journal article in ChemMedChem, published online on 2026-11-16. Written by Sumeyye Yilmaz and 3 co-authors. 58 references.
Abstract (original language)
Drug resistance remains a major barrier to HIV/AIDS treatment, underscoring the need for rapid evaluation of resistance mechanisms and candidate inhibitors. We present a multidrug machine‐learning framework using drug‐isolate fold‐change (DIF) data to predict resistance to human immunodeficiency virus type 1 (HIV‐1) reverse transcriptase inhibitors (RTIs). Unlike conventional isolate fold‐change (IF) models, DIF integrates viral mutation profiles with inhibitor‐specific molecular information, enabling simultaneous assessment of multiple RTIs, including unseen compounds. Artificial neural networks (ANN), XGBoost (XGB), LightGBM (LGBM), random forest (RF), and support vector regression (SVR) were evaluated. Across all algorithms, class‐specific DIF models consistently yielded higher correlation coefficients and lower mean squared errors than corresponding IF models. XGB‐DIF performed best overall, achieving a mean Pearson correlation coefficient of 0.914 and a mean squared error of 0.064. The models also captured pairwise resistance trends among FDA‐approved RTIs. External validation against an independent ChEMBL dataset yielded an accuracy of 0.824, an AUC of 0.901, and a Pearson correlation coefficient of 0.773 for the best‐performing XGB model. For clinically relevant variants mean absolute errors in logarithmic fold change were as low as 0.057, with near‐perfect resistance ranking for K103N, Y181C, and Y188L. These findings support the robustness and potential utility of the DIF framework.
Cite
APA
Yilmaz, S., Tunc, H., Sari, M., & Durdağı, S. (2026). Multidrug Machine Learning Models for Predicting Human Immunodeficiency Virus‐1 Reverse Transcriptase Inhibitor Resistance. ChemMedChem, 21(22). https://doi.org/10.1002/cmdc.70556
Vancouver
Yilmaz S, Tunc H, Sari M, Durdağı S. Multidrug Machine Learning Models for Predicting Human Immunodeficiency Virus‐1 Reverse Transcriptase Inhibitor Resistance. ChemMedChem. 2026;21(22). doi:10.1002/cmdc.70556
BibTeX
@article{Yilmaz2026,
author = {Yilmaz, Sumeyye and Tunc, Huseyin and Sari, Murat and Durdağı, Serdar},
title = {Multidrug Machine Learning Models for Predicting Human Immunodeficiency Virus‐1 Reverse Transcriptase Inhibitor Resistance},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {22},
doi = {10.1002/cmdc.70556}
}
EUVIMED